01061 ESSEX BIO-TECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.81X | Oper Margin | 23.0% |
|---|---|---|---|
| LT Debt/Equity | 5.4% | Net Margin | 18.4% |
| Total Debt/Equity | 8.8% | Return on Equity | 14.5% |
| Price/Book | 1.38X | Return on Assets | 10.3% |
| (HKD 5.170) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 307.22 | 275.26 | 225.41 | 345.97 | 218.93 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.6 | +22.1 | -34.9 | +58.0 | -27.6 |
| Earnings Per Share (HKD) | 0.541 | 0.483 | 0.393 | 0.6 | 0.379 |
| Earnings Per Share Growth (%) | +12.2 | +22.9 | -34.6 | +58.4 | -27.5 |
| Dividend Per Share (HKD) | 0.120 | 0.090 | 0.065 | 0.095 | 0.050 |
| P/E* (X) | 9.55 | 10.71 | 13.17 | 8.62 | 13.64 |
| Yield (%) | 2.32 | 1.74 | 1.26 | 1.84 | 0.97 |
| Dividend Share (%) | 22.16 | 18.65 | 16.55 | 15.83 | 13.20 |
| Book NAV (HKD) | 3.745 | 3.389 | 3.029 | 3.013 | 2.472 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 876.535 | 828.541 | +5.8 | 899.359 |
| Operating Result | 203.734 | 199.33 | +2.2 | 205.434 |
| Associates | -0.161 | -1.95 | -91.7 | -0.579 |
| Profit Before Taxation | 203.573 | 197.38 | +3.1 | 204.855 |
| Taxation | 40.172 | 39.94 | +0.6 | 35.044 |
| Profit /( Loss) After Taxation | 163.401 | 157.44 | +3.8 | 169.811 |
| Net Profit | 163.401 | 157.44 | +3.8 | 169.811 |
| Earnings Per Share () | 0.2882 | 0.2774 | +3.9 | 0.2972 |
| Dividend Per Share () | 0.0700 | 0.0600 | +16.7 | 0.0450 |
| Announcement Date | 2025-08-26 | 2024-08-26 | NA | 2023-08-16 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
